The effect of some iodinated contrast media on human plasma butyrylcholinesterase activity

Investigative Radiology

Volumn 33, Issue 5, 1998, Pages 308-310

  Mironidou, M ^a   Ximitidou, O ^b   Christopoulos, S ^b   Kokkas, B ^a,c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b GENERAL HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

Butyrylcholinesterase; Contrast media; Enzyme inhibition

Indexed keywords

CHOLINESTERASE; CONTRAST MEDIUM;

ACETYLCHOLINE RELEASE; ARTICLE; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME SYNTHESIS; HEMODILUTION; HUMAN; HYDROLYSIS; INTRAVENOUS PYELOGRAPHY; OSMOLALITY; PRIORITY JOURNAL;

EID: 0031927726     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199805000-00008     Document Type: Article

References (16)

1. Lang J, Lasser E. Nonspecific inhibition of enzymes by organic contrast media. J Med Chem 1971;14:2133-2136.
2. Howel M, Dawson P. Contrast agents and enzyme inhibition: Mechanisms. Br J Radiol 1985;58:845-848.
3. Lasser E, Lang J. Acetylcholinesterase inhibition by some organic contrast media. Invest Radiol 1973;10:68-71.
4. Livinston A, Sooriyamoorthy T, Griffin J. Anticholinesterase and hypotensive effects of some intravenous contrast media. Invest Radiol 1974;9:282-283.
5. Lasser E. Comment on anticholinesterase and hypotensive effects of some intravenous contrast media. Invest Radiol 1975;10:79-81.
6. Guidolett J, Louisot P, Amiel M, Liman K. Iodinated contrast agents: Effects on acetylcholine hydrolase. 1988;23(suppl 1):171-173.
7. Heller Brown J, Taylor P. Muscarinic receptor agonists and antagonists. In: Hardman J, Limbird L, eds. Goodman and Gilman's The pharmacological basis of therapeutics. New York: McGraw Hill, 1996.
8. Lefkowitz R, Hoffman B, Taylor P. Neurotransmission. In: Hardman J, Limbird L, eds. Goodman and Gilman's The pharmacological basis of therapeutics. New York: McGraw Hill, 1996.
9. Foldes F, VanHess G, Shanor S, Baart N. Interrelationship of suxamethonium, suxethonium and succinylcholine and human cholinesterase. Fed Proc 1956;15:422-427.
10. Foldes F, Davis D, Shanor S, VanHess G. Hydrolysis of ester type local anesthetics and their halogenated analogs by purified plasma cholinesterase. J Am Chem Soc 1955;77:5149-5155.
11. Zsigmond E, Robins G. The effect of a series of anticancer drugs on plasma cholinesterase activity. Can Anaesth Soc J 1972;19:75-79.
12. Pantuck E. Ecothiopate iodine eye drops and prolonged response to suxamethonium. Br J Anaesth 1966;38:406-409.
13. Tzouveleki M, Kouvelas D, Salpigides G, Sbarounis Ch, Paradelis A. The effect of erythromycin ethylsuccinate on serum butyryl-cholinesterase activity. J Chemotherapy 1991;2(suppl)4:93-94.
14. Paradelis A, Tzouveleki M. Kouvelas D, Salpigides G, Pagalis A. Quinolones and serum butyrylcholinesterase activity. J Chemotherapy 1996;7(suppl 4):34-35.
15. Knedel M, Bottger R. Eine kinetische methode zur bestimmung der aktivitat der pseudocholinesterase. Klin Wschr 1967;45:325-327.
16. Grainger R. Osmolality and osmolality related side effects. In: Felix R, Fischer H, Kormano M, et al, eds. Contrast media: From the past to the future. Stuttgart: Georg Thieme Verlag, 1987.